PITTSBURGH, March 10, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug ...
PITTSBURGH, Jan. 24, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug ...
The Annals of Pharmacotherapy. 2006;40(7):1327-1335. In overdose situations, modified-release delivery systems may continue to release their active ingredients; therefore, the management of an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback